Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report
Open Access
- 12 July 2022
- journal article
- research article
- Published by Elsevier in Biologicals
- Vol. 78, 17-26
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
This publication has 16 references indexed in Scilit:
- Modern science for better quality control of medicinal products “Towards global harmonization of 3Rs in biologicals”: The report of an EPAA workshopBiologicals, 2017
- Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccines.2016
- Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeiasRegulatory Toxicology and Pharmacology, 2015
- The Selection and Use of Essential Medicines2015
- Historical Data Analyses and Scientific Knowledge Suggest Complete Removal of the Abnormal Toxicity Test as a Quality Control TestJournal of Pharmaceutical Sciences, 2014
- The consistency approach for quality control of vaccines – A strategy to improve quality control and implement 3RsBiologicals, 2011
- The target animal safety test--is it still relevant?2002
- The Target Animal Safety Test—Is it Still Relevant?Biologicals, 2002
- Elimination of abnormal toxicity test for sera and certain vaccines in the European PharmacopoeiaVaccine, 1997
- [Is the abnormal toxicity test still relevant for the safety of vaccines, sera and immunoglobulins?]1996